摘要
慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary diseases,AECOPD)抗生素治疗仍存争议。最新研究表明在AECOPD中,动态监测降钙素原(procalcitonin,PCT)水平对抗生素的应用有明确的指导作用,可以减少不必要的抗生素应用,缩短应用时间,防止耐药。PCT指导策略在被建议成为全球AECOPD抗生素治疗方案之前,尚面临几个关键问题有待解决。
The role of antimicrobial in acute exacerbation of chronic obstructive pulmonary diseases (AECOPD) remains controversial. Recent reports have shown that the dynamic determination for procaleitonin(PCT) could instruct antibiotic use,decrease unnecessary exposure time, shorten the course of treatment,and prevent antibiotic resistance in AECOPD. But, some important questions remain before PCT guided therapy can be recommended as a worldwide standard approach to AECOPD antimierobial management.
出处
《国际呼吸杂志》
2008年第23期1460-1463,共4页
International Journal of Respiration
关键词
降钙素原
慢性阻塞性肺疾病急性加重期
抗生素治疗
Procalcitonin
Acute exacerbation of chronic obstructive pulmonary diseases
Antimicrobial